Thursday, May 26, 2016

Theranos sued over blood tests, in proposed class action – Reuters

n”>Blood-testing firm Theranos Inc was sued regard Thursday, accused of endangering customer healthiness with “massive failures” that misrepresented the accuracy and top quality of its blood tests, according to court papers.

The proposed class action was brought in the U.S. District Court for the Northern District of California by the law firm Hagens Berman Sobol Shapiro LLP.

The complaint accuses the firm of breach of contract, false marketing and consumer fraud, among others claims. It estimated that thousands of consumers can be eligible to connect the lawsuit, citing Theranos’ claims that it had carried out much more compared to 6 million tests.

Officals at Theranos did not right away respond to requests for comment.

Theranos last week cautioned U.S. federal healthiness regulators that it voided outcomes from its Edison blood-testing machines for 2 years, the Wall Street Diary reported, citing a individual familiar along with the matter. The firm informed the Facilities for Medicare and Medicaid Programs that it has actually issued tens of thousands of corrected blood-test reports to doctors and patients, nullifying some outcomes and revising others, the Diary reported. Theranos when touted its Edison device as a ground-breaking technology able to test blood from merely a pinprick. The complaint focuses regard components published by the two Theranos and Walgreens Boots Alliance, which had agreed to provide blood testing from Theranos’ Edison device at dozens of health Facilities in Walgreen’s stores in Arizona and California.

CMS said in January that the blood-testing company’s routines violated a number of clinical-laboratory regulations, jeopardizing patient healthiness and safety. Theranos, which just recently expanded its board to contain Dr. Fabrizio Bonanni, a former Amgen Inc and Baxter Worldwide Inc executive, has actually been under investigation by a number of U.S. regulators in the recent past.

(Reporting By Deena Beasley; Editing by David Gregorio)

No comments:

Post a Comment